GlassScriptPhysician profile
Ricky W Lee
NPI 1932357571
$1,463.66
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,451 · 2021: $12.60.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $316.06 | 2019 | |
| Eisai INC. | $164.25 | 2019 | |
| Sunovion Pharmaceuticals INC. | $161.49 | 2019 | |
| Supernus Pharmaceuticals, INC. | $147.92 | 2019 | |
| Amgen INC. | $119.96 | 2019 | |
| Greenwich Biosciences, INC. | $86.96 | 2019 | |
| Mallinckrodt Enterprises LLC | $64.80 | 2019 | |
| Biogen, INC. | $58.70 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $56.87 | 2019 | |
| Alexion Pharmaceuticals, INC. | $51.89 | 2019 | |
| Acorda Therapeutics, INC | $47.42 | 2019 | |
| Livanova USA, INC. | $38.71 | 2019 | |
| Ucb, INC. | $32.39 | 2019 | |
| Adamas Pharmaceuticals, INC. | $30.27 | 2019 | |
| Lundbeck LLC | $29.57 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $18.44 | 2019 | |
| Ge Healthcare | $12.83 | 2019 | |
| Zogenix INC. | $12.60 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $12.53 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricky Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.